title: Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.
authors.forename: Richard
authors.initials: R
authors.lastname: Quek
authors.forename: Wan Teck
authors.initials: WT
authors.lastname: Lim
authors.forename: Kian Fong
authors.initials: KF
authors.lastname: Foo
authors.forename: Wen Hsin
authors.initials: WH
authors.lastname: Koo
authors.forename: Afidah
authors.initials: A
authors.lastname: A-Manaf
authors.forename: Han Chong
authors.initials: HC
authors.lastname: Toh
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D000069287:Capecitabine; D003841:Deoxycytidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004338:Drug Combinations; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D010071:Oxaloacetates; D012189:Retrospective Studies; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D004338:Drug Combinations; D009944:Organoplatinum Compounds; D010071:Oxaloacetates; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil